Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 24, 2017

Study Completion Date

May 24, 2017

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Anti-TNF Biologics Therapy

Trial Locations (8)

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge

E1 4DG

Barts Health NHS Trust, Experimental Medicine & Rheumatology, Mile End Hospital, London

E11 1NR

Barts Health NHS Trust,Department of Rheumatology,Whipps Cross University Hospital, London

NW1 2PG

University College London Hospitals NHS Foundation Trust, Rheumatology Department, London

Unknown

Imperial College Healthcare NHS Trust, London

M13 9WL

Central Manchester University Hospitals NHS Foundation Trust, The Kellgren Centre for Rheumatology, Manchester

NE1 4LP

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle

OX3 7LD

Oxford University Hospitals NHS Trust, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford

All Listed Sponsors
lead

Queen Mary University of London

OTHER

NCT02620189 - Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα | Biotech Hunter | Biotech Hunter